Physician profile
Michael E Rudman
NPI 1720085145
$1,529.72
in general payments reported to CMS, 2019-2025
14 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.78 · 2020: $334 · 2021: $454 · 2022: $75.35 · 2024: $180 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $770.37 | 2020-2024 | Senza |
| Globus Medical, INC. | $275.50 | 2025 | Senza |
| Medtronic, INC. | $83.96 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $78.45 | 2021-2022 | |
| Biotronik Nro, INC. | $65.69 | 2025 | Prospera |
| Abbott Laboratories | $51.87 | 2019-2021 | |
| Medtronic USA, INC. | $41.74 | 2019 | |
| Vertiflex, INC. | $31.97 | 2019 | |
| Collegium Pharmaceutical, INC. | $30.00 | 2020-2021 | |
| Chiesi USA, INC. | $28.67 | 2021 | |
| Si-Bone, INC. | $24.19 | 2021 | |
| Abbvie INC. | $16.55 | 2024 | |
| Saluda Medical Americas, INC. | $15.75 | 2024 | Evoke |
| Vertex Pharmaceuticals Incorporated | $15.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rudman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.